PRKAA2 and metabolic dysfunction-associated steatotic liver disease: Previous studies have demonstrated that Zingerone can activate AMPK in different pathological contexts; for example, it was shown to ameliorate non-alcoholic fatty liver disease (NAFLD) in rats through AMPK pathway activation and to protect against vascular calcification via AMPK-dependent signaling.